Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
22.5M
-
Number of holders
-
29
-
Total 13F shares, excl. options
-
2.61M
-
Shares change
-
+4.62K
-
Total reported value, excl. options
-
$6.4M
-
Value change
-
+$11.6K
-
Number of buys
-
6
-
Number of sells
-
-9
-
Price
-
$2.45
Significant Holders of iBio, Inc. - Common Stock (IBIO) as of Q4 2024
32 filings reported holding IBIO - iBio, Inc. - Common Stock as of Q4 2024.
iBio, Inc. - Common Stock (IBIO) has 29 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.61M shares
of 22.5M outstanding shares and own 11.63% of the company stock.
Largest 10 shareholders include Lynx1 Capital Management LP (862K shares), Ikarian Capital, LLC (600K shares), ADAR1 Capital Management, LLC (416K shares), Opaleye Management Inc. (375K shares), BOOTHBAY FUND MANAGEMENT, LLC (159K shares), GEODE CAPITAL MANAGEMENT, LLC (83.8K shares), VANGUARD GROUP INC (73.1K shares), DIMENSIONAL FUND ADVISORS LP (24.2K shares), NORTHERN TRUST CORP (10.2K shares), and BlackRock, Inc. (5.57K shares).
This table shows the top 29 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.